vTv Therapeutics Inc. (VTVT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Research and development | 4,103 | 2,830 | 3,224 | 3,439 |
| General and administrative | 3,618 | 3,673 | 3,282 | 3,716 |
| Total operating expenses | 7,721 | 6,503 | 6,506 | 7,155 |
| Operating loss | -7,721 | -6,503 | -6,506 | -7,155 |
| Interest income | 275 | 331 | 504 | 553 |
| Other income (expense), net-Nonrelated Party | 12 | - | - | - |
| Other income (expense), net-Related Party | 54 | - | - | - |
| Other expense, net | - | -45 | 85 | 72 |
| Loss before income taxes and noncontrolling interest | -7,380 | -6,217 | -5,840 | -6,409 |
| Income tax provision | - | - | - | - |
| Net loss before noncontrolling interest | -7,380 | -6,217 | -5,840 | -6,409 |
| Less net loss attributable to noncontrolling interest | -1,334 | -1,125 | -1,057 | -1,229 |
| Net loss attributable to vtv therapeutics inc | -6,046 | -5,092 | -4,783 | -5,180 |
| Basic eps | - | -0.77 | -0.88 | -0.81 |
| Diluted eps | - | -0.77 | -0.88 | -0.81 |
| Basic average shares | - | 6,582,844 | 5,456,307 | 6,403,444 |
| Diluted average shares | - | 6,582,844 | 5,456,307 | 6,403,444 |